FDA Drug recall D-1382-2014
CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, N…
- FDA Drug
- Class I
- terminated
- Published 2014-06-18
On 2014-06-18 the FDA classified a Class I recall of CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, N… by Cubist Pharmaceuticals, citing presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1382-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2014-04-17 |
| Published | 2014-06-18 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Cubist Pharmaceuticals |
| Distribution | US |
Product
CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.
Reason
Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
Identifiers
| upc | 367919011016 |
|---|---|
| code_info | Lot #: 280453F, Exp 04/16 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1382-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.